These findings emphasise the need to address early diagnosis and comorbidities in non-metastatic prostate cancer, which could improve overall survival.
Chikwati et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: